<DOC>
	<DOC>NCT00721422</DOC>
	<brief_summary>1. To investigate the effect of kidney function on the elimination of a single dose of PD 0332334 from the body. 2. To investigate the safety and tolerability of a single dose of PD 0332334 in patients with impaired kidney function.</brief_summary>
	<brief_title>A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.</brief_title>
	<detailed_description>Additional Study Purpose Details: Investigation of the pharmacokinetics, safety, and tolerability of a single dose of PD 0332334 in patients with impaired renal function. On February 23rd 2009, a decision to terminate further development for PD 0332334 was communicated to investigators in this study. The decision to terminate this study was not based on any safety concerns.</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Healthy volunteers OR subjects with kidney impairment 1. Receiving hemodialysis 2. clinically significant or unstable medical disease other than kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Pharmacokinetics of PD 0332334 in subjects with renal insufficiency</keyword>
</DOC>